<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<!-- Warning : Check the xml:lang = ko or en -->
<article article-type="research-article" dtd-version="1.0" xml:lang="ko" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">KJM</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Medicine</journal-title><abbrev-journal-title>Korean J Med</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">1738-9364</issn>
<issn pub-type="epub">2289-0769</issn>
<publisher>
<publisher-name>The Korean Journal of Medicine</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3904/kjm.2021.96.2.152</article-id>
<article-id pub-id-type="publisher-id">kjm-96-2-152</article-id>
<article-categories>
<subj-group>
<subject>Erratum</subject></subj-group></article-categories>
<title-group>
<article-title>부신 질환의 진단을 위한 혈액 검사</article-title>
<trans-title-group>
<trans-title xml:lang="en">Blood Tests for the Diagnosis of Adrenal Diseases</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Cha</surname><given-names>Seon-Ah</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>차</surname><given-names>선아</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af1-kjm-96-2-152"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name-alternatives>
<name name-style="western" xml:lang="en"><surname>Moon</surname><given-names>Sung-Dae</given-names></name>
<name name-style="eastern" xml:lang="ko"><surname>문</surname><given-names>성대</given-names></name>
</name-alternatives>
<xref ref-type="aff" rid="af2-kjm-96-2-152"><sup>2</sup></xref>
</contrib>
<aff-alternatives id="af1-kjm-96-2-152">
<aff xml:lang="en"><label>1</label>Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, <country>Korea</country></aff>
<aff xml:lang="ko"><label>1</label>가톨릭대학교 의과대학 성빈센트병원 내분비내과</aff>
</aff-alternatives>
<aff-alternatives id="af2-kjm-96-2-152">
<aff xml:lang="en"><label>2</label>Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, <country>Korea</country></aff>
<aff xml:lang="ko"><label>2</label>가톨릭대학교 의과대학 인천성모병원 내분비내과</aff>
</aff-alternatives>
</contrib-group>
<pub-date pub-type="ppub">
<day>1</day>
<month>4</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>1</day>
<month>4</month>
<year>2021</year></pub-date>
<volume>96</volume>
<issue>2</issue>
<fpage>152</fpage>
<lpage>154</lpage>
<permissions>
<copyright-statement xml:lang="en">Copyright &#x000A9; 2021 The Korean Association of Internal Medicine</copyright-statement>
<copyright-year>2021</copyright-year>
<license xml:lang="en">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
</article-meta>
</front>
<body>
<p>Korean J Med 2018;93:532-537. <ext-link xlink:href="https://doi.org/10.3904/kjm.2018.93.6.532" ext-link-type="uri">https://doi.org/10.3904/kjm.2018.93.6.532</ext-link></p>
<p>다음과 같이 Table 내 오류가 있어 수정합니다.</p>
</body>
<back>
<sec sec-type="display-objects" xml:lang="en">
		<title>Table</title>
		<table-wrap id="t1-kjm-96-2-152" position="float">
<label>Table 1.</label>
<caption><p>Drugs that may affect the metabolism of plasma cortisol, aldosterone, renin, and catecholamines</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Adrenal hormone</th>
<th align="center" valign="middle">Drug group</th>
<th align="center" valign="middle">Drugs</th>
<th align="center" valign="middle">Recommended withdrawal time</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Plasma cortisol&#x02193;<sup><xref rid="tfn1-kjm-96-2-152" ref-type="table-fn">a</xref></sup> after overnight DST</td>
<td valign="top" align="left">Drugs&#x02002;that&#x02002;increase&#x02002;metabolism&#x02002;by&#x02002;inducing&#x02002;CYP3A4</td>
<td valign="top" align="left">Phenytoin, barbiturates, carbamazepine, rifampicin, alcohol, estrogen, mitotane</td>
<td valign="top" align="center">2 weeks [7]</td>
</tr>
<tr>
<td valign="top" align="left">Plasma cortisol&#x02191;<sup><xref rid="tfn2-kjm-96-2-152" ref-type="table-fn">b</xref></sup> after overnight DST</td>
<td valign="top" align="left">Drugs&#x02002;that&#x02002;decrease&#x02002;metabolism&#x02002;by&#x02002;inhibiting&#x02002;CYP3A4</td>
<td valign="top" align="left">Itraconazole, ritonavir, diltiazem, cimetidine</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="5">PAC/PRA ratio&#x02193;<sup><xref rid="tfn1-kjm-96-2-152" ref-type="table-fn">a</xref></sup> [19]</td>
<td valign="top" align="left">Angiotensin-converting enzyme inhibitors</td>
<td valign="top" align="left">Captopril, enalapril, fosinopril, lisinopril, ramipril</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Angiotensin receptor blockers</td>
<td valign="top" align="left">Losartan, valsartan, irbesartan, candesartan, telmisartan, eprosartan, olmesartan, fimasartan</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Dihydropyridine calcium channel blockers</td>
<td valign="top" align="left">Nifedipine, amlodipine</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Mineralocorticoid antagonists</td>
<td valign="top" align="left">Spironolactone, eplerenone</td>
<td valign="top" align="center">4 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Diuretics</td>
<td valign="top" align="left">Hydrochlorothiazide, furosemide, torsemide</td>
<td valign="top" align="center">4 weeks</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="4">PAC/PRA ratio&#x02191;<sup><xref rid="tfn2-kjm-96-2-152" ref-type="table-fn">b</xref></sup> [19]</td>
<td valign="top" align="left">&#x003B2;-blockers</td>
<td valign="top" align="left">Atenolol, bisoprolol, metoprolol, nebivolol, esmolol, propranolol, carvedilol, labetalol, nadolol</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">NSAIDs</td>
<td valign="top" align="left">Ibuprofen, dexibuprofen, naproxen, fenoprofen, ketoprofen, loxoprofen, ketorolac, aceclofenac, diclofenac, piroxicam, meloxicam</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Renin inhibitor</td>
<td valign="top" align="left">Aliskiren</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Central agonists</td>
<td valign="top" align="left">Clonidine, &#x003B1;-methyldopa</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="5">Plasma catecholamines [20]</td>
<td valign="top" align="left">Alpha-blockers</td>
<td valign="top" align="left">Phenoxybenzamine, doxazosin</td>
<td valign="top" align="center">15 days</td>
</tr>
<tr>
<td valign="top" align="left">Tricyclic antidepressants</td>
<td valign="top" align="left">Amitriptyline, imipramine, nortriptyline</td>
<td valign="top" align="center">3 days</td>
</tr>
<tr>
<td valign="top" align="left">Antihistamine</td>
<td valign="top" align="left">Promethazine</td>
<td valign="top" align="center">3 days</td>
</tr>
<tr>
<td valign="top" align="left">Sympathomimetics</td>
<td valign="top" align="left">Salbutamol, terbutaline, bambuterol</td>
<td valign="top" align="center">3 days</td>
</tr>
<tr>
<td valign="top" align="left">Antipsychotics</td>
<td valign="top" align="left">Chlorpromazine, haloperidol, perphenazine, amisulpride, clozapine, olanzapine, quetiapine, risperidone</td>
<td valign="top" align="center">10 days-1 month for depot</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>DST, dexamethasone suppression test; CYP3A4, cytochrome P450 3A4; PAC, plasma aldosterone concentration; PRA, plasma renin activity; NSAIDs, nonsteroidal anti-inflammatory drugs.</p></fn>
<fn id="tfn1-kjm-96-2-152"><label>a</label><p>Possibility of false-negative results.</p></fn>
<fn id="tfn2-kjm-96-2-152"><label>b</label><p>Possibility of false-positive results.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="t2-kjm-96-2-152" position="float">
<label>Table 1.</label>
<caption><p>Drugs that may affect the metabolism of plasma cortisol, aldosterone, renin, and catecholamines</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Adrenal hormone</th>
<th align="center" valign="middle">Drug group</th>
<th align="center" valign="middle">Drugs</th>
<th align="center" valign="middle">Recommended withdrawal time</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Plasma cortisol&#x02191;after overnight DST</td>
<td valign="top" align="left">Drugs&#x02002;that&#x02002;increase&#x02002;metabolism&#x02002;by&#x02002;inducing&#x02002;CYP3A4</td>
<td valign="top" align="left">Phenytoin, barbiturate, carbamazepine, rifampicin, alcohol, mitotane</td>
<td valign="top" align="center">2 weeks [7]</td>
</tr>
<tr>
<td valign="top" align="left">Plasma cortisol&#x02193;after overnight DST</td>
<td valign="top" align="left">Drugs&#x02002;that&#x02002;decrease&#x02002;metabolism&#x02002;by&#x02002;inhibiting&#x02002;CYP3A4</td>
<td valign="top" align="left">Itraconazole, ritonavir, diltiazem, cimetidine</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="5">PAC/PRA ratio &#x02193;[8]</td>
<td valign="top" align="left">Angiotensin-converting enzyme inhibitor</td>
<td valign="top" align="left">Captopril, Enalapril, Fosinopril, Lisinopril, Ramipril</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Angiotensin receptor blocker</td>
<td valign="top" align="left">Losartan, Valsartan, Irbesartan, Candesartan, Telmisartan, E prosartan, Olmesartan, Fimasartan</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Dihydropyridine calcium channel blocker</td>
<td valign="top" align="left">Nifedipine, Amlodipine</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Mineralocorticoid antagonist</td>
<td valign="top" align="left">Spironolactone, Eplerenone</td>
<td valign="top" align="center">4 weeks</td>
</tr>
<tr>
<td valign="top" align="left">Diuretics</td>
<td valign="top" align="left">Hydrochlorothiazide, Furosemide, Torsemide</td>
<td valign="top" align="center">4 weeks</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="4">PAC/PRA ratio&#x02191;[8]</td>
<td valign="top" align="left">&#x003B2;-blockers</td>
<td valign="top" align="left">Atenolol, Bisoprolol, Metoprolol, Nebivolol, Esmolol, Propranolol, Carvedilol, Labetalol, Nadolol</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">NSAIDs</td>
<td valign="top" align="left">Ibuprofen, Dexibuprofen, Naproxen, Fenoprofen, Ketoprofen, Loxoprofen, Ketorolac, Aceclofenac, Diclofenac, Piroxicam, Meloxicam</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">renin inhibitor</td>
<td valign="top" align="left">Aliskiren</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left">central agonist</td>
<td valign="top" align="left">clonidine, &#x003B1;-methyldopa</td>
<td valign="top" align="center">2 weeks</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="5">Plasma catecholamines [9]</td>
<td valign="top" align="left">Alpha-blocker</td>
<td valign="top" align="left">Phenoxybenzamine, Doxazosin</td>
<td valign="top" align="center">15 days</td>
</tr>
<tr>
<td valign="top" align="left">Tricyclic antidepressant</td>
<td valign="top" align="left">Amitriptyline, Imipramine, Nortriptyline</td>
<td valign="top" align="center">3 days</td>
</tr>
<tr>
<td valign="top" align="left">Antihistamine</td>
<td valign="top" align="left">Promethazine</td>
<td valign="top" align="center">3 days</td>
</tr>
<tr>
<td valign="top" align="left">Sympathomimetic</td>
<td valign="top" align="left">Salbutamol, Terbutaline, Bambuterol,</td>
<td valign="top" align="center">3 days</td>
</tr>
<tr>
<td valign="top" align="left">Antipsychotic</td>
<td valign="top" align="left">Chlorpromazine, Haloperidol, Perphenazine, Amisulpride, Clozapine, Olanzapine, Quetiapine, Risperidone</td>
<td valign="top" align="center">10 days-1 month for depot</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>DST, dexamethasone suppression test; CYP3A4, cytochrome P450 3A4; PAC, plasma aldosterone concentration; PRA, plasma renin activity; NSAIDs, nonsteroidal anti-inflammatory drugs.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back></article>